Department of Internal Medicine, Division of Cardiology MedStar Washington Hospital Center, Washington, DC, USA.
Am J Cardiol. 2012 Oct 15;110(8):1164-8. doi: 10.1016/j.amjcard.2012.05.057. Epub 2012 Jul 6.
Disturbances in atrioventricular conduction and the additional need for a permanent pacemaker are recognized complications after transcatheter aortic valve replacement (TAVR). We analyzed the incidence of postprocedural conduction disorders and the need for permanent pacemaker implantation in patients undergoing TAVR with the Edwards SAPIEN valve. In 125 consecutive patients with symptomatic, severe aortic stenosis undergoing TAVR, a standard 12-lead electrocardiogram was obtained before and serially after the procedure. The cohort was divided into 2 groups with regard to the post-TAVR appearance of conduction disturbances, defined as left bundle branch block, right bundle branch block, fascicular hemiblock, atrioventricular block, and the need for a permanent pacemaker. The patients with and without conduction disturbances were compared. After TAVR, 19 patients (15.2%) met the study definition of a "new conduction defect" and 5 patients (4%) required a permanent pacemaker because of an advanced atrioventricular block. New left bundle branch block appeared in 5 patients (4%) and left anterior hemiblock in 9 (7.2%). No new right bundle branch block or left posterior hemiblock was observed. Although most baseline, echocardiographic, and procedural characteristics were equally distributed, the patients with new conduction disturbances more often had diabetes mellitus and peripheral vascular disease. Also, they more often were taking an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker, and the procedure was performed more often with apical access (12 [63.2%] vs 7 with femoral access [36.8%], p = 0.002). In conclusion, although the incidence of conduction disturbances was high after TAVR using the Edwards SAPIEN valve, with a significant increase in the rate of left bundle branch block and left anterior hemiblock, the need for permanent pacemaker implantation after TAVR with this valve remained low.
房室传导障碍和对永久性起搏器的额外需求是经导管主动脉瓣置换术(TAVR)后的公认并发症。我们分析了接受 Edwards SAPIEN 瓣膜 TAVR 的患者术后传导障碍的发生率和对永久性起搏器植入的需求。在 125 例连续接受症状性严重主动脉瓣狭窄 TAVR 的患者中,在术前和术后连续获得标准 12 导联心电图。根据 TAVR 后传导障碍的出现情况,将队列分为 2 组,定义为左束支传导阻滞、右束支传导阻滞、束支传导阻滞、房室传导阻滞和需要永久性起搏器。比较了有和无传导障碍的患者。TAVR 后,19 例(15.2%)患者符合“新传导缺陷”的研究定义,5 例(4%)因高级房室传导阻滞需要永久性起搏器。5 例(4%)出现新的左束支传导阻滞,9 例(7.2%)出现左前分支阻滞。未观察到新的右束支传导阻滞或左后分支阻滞。尽管大多数基线、超声心动图和手术特征分布均匀,但出现新传导障碍的患者更常患有糖尿病和外周血管疾病。此外,他们更常服用血管紧张素转换酶抑制剂或血管紧张素 II 受体阻滞剂,且手术更多地采用心尖入路(12 例[63.2%]与经股动脉入路 7 例[36.8%],p = 0.002)。总之,尽管使用 Edwards SAPIEN 瓣膜进行 TAVR 后传导障碍的发生率较高,左束支传导阻滞和左前分支阻滞的发生率显著增加,但该瓣膜 TAVR 后永久性起搏器植入的需求仍然较低。